Julie Cherrington

Julie Cherrington is a seasoned professional in the biotechnology sector, holding multiple board positions and leadership roles. Current engagements include Board Member at Elevation Oncology since March 2024, Chairperson of the Board at Tolremo Therapeutics and Actym Therapeutics, Inc. since April 2023 and March 2022 respectively, and Board Member at Syncona Limited and Sardona Therapeutics. Julie also serves as a Venture Partner at Brandon Capital Partners, alongside previous board memberships at MycRx and KisoJi Biotechnology. Julie's extensive academic background includes a Postdoctoral Fellowship at the University of California, San Francisco, and a PhD in Microbiology and Immunology from the University of Minnesota and Stanford University. Additional degrees include a Master of Science in Microbiology and a Bachelor of Science in Biology, both from the University of California, Davis.